ADAR1 Capital Management, LLC

CIK

1940272

City

AUSTIN

State / Country

TX

Stock

PTGX — Protagonist Therapeutics, Inc

Top Portfolio Positions

283 positions · $1,622,497,451 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio	Open
ABVX	Abivax S.A. Healthcare	1,438,019	$160,123,415	9.87%
PTGX	Protagonist Therapeutics, Inc Healthcare	994,119	$104,780,142	6.46%
ROIV	Roivant Sciences Ltd. Healthcare	3,285,906	$91,019,596	5.61%
IMVT	Immunovant, Inc. Healthcare	2,679,010	$66,546,608	4.10%
TERN	Terns Pharmaceuticals, Inc. Healthcare	1,114,699	$58,766,931	3.62%
SPY	Spdr S&P 500 ETF Trust	75,940	$49,386,819	3.04%
CYTK	Cytokinetics Inc Healthcare	632,556	$41,691,765	2.57%
CRNX	Crinetics Pharmaceuticals, Inc. Healthcare	1,139,331	$41,380,501	2.55%
DNLI	Denali Therapeutics Inc. Healthcare	1,871,455	$35,931,936	2.21%
BEAM	Beam Therapeutics Inc. Healthcare	1,446,375	$34,467,116	2.12%

Portfolio Trend

10 quarters · across all stocks

Holdings in PTGX

Compact Export CSV

Shares Held

Position Value (USD)

11 quarters on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$104,780,142	994,119	-5.2%	Shares	Sole	2026-05-18
2025-12-31	$91,634,333	1,049,168	+6.1%	Shares	Sole	2026-02-18
2025-09-30	$65,711,360	989,182	+4.3%	Shares	Sole	2025-11-14
2025-06-30	$52,399,773	948,069	+0.9%	Shares	Sole	2025-08-14
2025-03-31	$45,442,392	939,669	-7.9%	Shares	Sole	2025-05-15
2024-12-31	$39,384,853	1,020,333	+673.0%	Shares	Sole	2025-02-13
2024-12-31	$5,095,200	132,000	-86.5%	Call	Sole	2025-02-13
2024-09-30	$44,158,275	981,295	-38.8%	Shares	Sole	2024-11-14
2024-06-30	$55,576,243	1,603,932	+104.2%	Shares	Sole	2024-08-13
2024-03-31	$22,728,999	785,655	+291.1%	Shares	Sole	2024-05-15
2023-12-31	$4,605,696	200,859	—	Shares	Sole	2024-02-14
No 13F history on record for this holder in this stock.